In patients with metastatic colon cancer responding to treatment with FOLFOX / FOLFIRI with bevacizumab who develop a symptomatic PE, do you continue bevacizumab after treating the PE?
Package insert indicates discontinuing bevacizumab in PE and there are no guidelines on re-challenging after acute clot is managed.
Community PollStarted
Do you resume bevacizumab in patients with metastatic colon cancer after treatment for PE?
111 physicians have voted
Join Mednetto vote and see how they answered.